Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Raynaud

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Urology|August 23, 2011
High incidence of predominant Gleason pattern 4 localized prostate cancer is associated with low serum testosteroneHenry Botto, Yann Neuzillet, Thierry Lebret, et al.
Steroids|July 13, 2004
Development of a highly sensitive and specific new testosterone time-resolved fluoroimmunoassay in human serumJean Fiet, Frank Giton, Ibrahim Fidaa, et al.
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Comparison of oral versus transdermal testosterone supplementation in hypogonadal menJean-Pierre Raynaud, Michel Colle, Michèle Pujos-Gautraud, et al.
Clinical Chemistry|December 31, 2005
Serum bioavailable testosterone: assayed or calculated?Frank Giton, Jean Fiet, Jérôme Guéchot, et al.
Hormone Molecular Biology and Clinical Investigation|June 6, 2015
Obesity and hypogonadism are associated with an increased risk of predominant Gleason 4 pattern on radical prostatectomy specimenYann Neuzillet, Jean-Pierre Raynaud, Thierry Lebret, et al.
The Journal of Sexual Medicine|July 22, 2008
Aging Male Questionnaire in normal and complaining menJean-Pierre Raynaud, Jean Tichet, Catherine Born, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 8, 2008
Efficacy and safety of a new testosterone-in-adhesive matrix patch applied every 2 days for 1 year to hypogonadal menJean-Pierre Raynaud, Jean-Jacques Legros, Jacques Rollet, et al.
Clinical Chemistry|October 13, 2007
Determination of bioavailable testosterone [non sex hormone binding globulin (SHBG)-bound testosterone] in a population of healthy French men: influence of androstenediol on testosterone binding to SHBGFrank Giton, Saïk Urien, Catherine Born, et al.
The French Journal of Urology|June 2, 2024
Intraprostatic hormone dosage: Validation of a novel prostate biopsy techniqueMaxime Pattou, Yann Neuzillet, Jean-Pierre Raynaud, et al.
World Journal of Urology|February 1, 2021
PSA and obesity among men with localized prostate cancer: results of the ANDROCAN studyMatthias E Meunier, Yann Neuzillet, Jean-François Dreyfus, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Urology|August 23, 2011
High incidence of predominant Gleason pattern 4 localized prostate cancer is associated with low serum testosteroneHenry Botto, Yann Neuzillet, Thierry Lebret, et al.
Steroids|July 13, 2004
Development of a highly sensitive and specific new testosterone time-resolved fluoroimmunoassay in human serumJean Fiet, Frank Giton, Ibrahim Fidaa, et al.
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Comparison of oral versus transdermal testosterone supplementation in hypogonadal menJean-Pierre Raynaud, Michel Colle, Michèle Pujos-Gautraud, et al.
Clinical Chemistry|December 31, 2005
Serum bioavailable testosterone: assayed or calculated?Frank Giton, Jean Fiet, Jérôme Guéchot, et al.
Hormone Molecular Biology and Clinical Investigation|June 6, 2015
Obesity and hypogonadism are associated with an increased risk of predominant Gleason 4 pattern on radical prostatectomy specimenYann Neuzillet, Jean-Pierre Raynaud, Thierry Lebret, et al.
The Journal of Sexual Medicine|July 22, 2008
Aging Male Questionnaire in normal and complaining menJean-Pierre Raynaud, Jean Tichet, Catherine Born, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 8, 2008
Efficacy and safety of a new testosterone-in-adhesive matrix patch applied every 2 days for 1 year to hypogonadal menJean-Pierre Raynaud, Jean-Jacques Legros, Jacques Rollet, et al.
Clinical Chemistry|October 13, 2007
Determination of bioavailable testosterone [non sex hormone binding globulin (SHBG)-bound testosterone] in a population of healthy French men: influence of androstenediol on testosterone binding to SHBGFrank Giton, Saïk Urien, Catherine Born, et al.
The French Journal of Urology|June 2, 2024
Intraprostatic hormone dosage: Validation of a novel prostate biopsy techniqueMaxime Pattou, Yann Neuzillet, Jean-Pierre Raynaud, et al.
World Journal of Urology|February 1, 2021
PSA and obesity among men with localized prostate cancer: results of the ANDROCAN studyMatthias E Meunier, Yann Neuzillet, Jean-François Dreyfus, et al.
Pageof 4